0001437749-20-018608.txt : 20200824 0001437749-20-018608.hdr.sgml : 20200824 20200824164912 ACCESSION NUMBER: 0001437749-20-018608 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200820 FILED AS OF DATE: 20200824 DATE AS OF CHANGE: 20200824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones Andrew D. CENTRAL INDEX KEY: 0001811872 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 201128426 MAIL ADDRESS: STREET 1: 2000 POWELL STREET STREET 2: SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 4 1 rdgdoc.xml FORM 4 X0306 4 2020-08-20 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001811872 Jones Andrew D. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 1 CFO Stock Option (right to buy) 0.99 2020-08-20 4 A 0 25000 0 A 2021-08-20 2030-08-20 Common Stock 25000 25000 D The stock option grant will vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting very three months thereafter. /s/ Andrew D. Jones 2020-08-24